Vaginal Slings Market
Vaginal Slings Market Size, Share Analysis, By Type (Transobturator Slings, Mini /Single Incision Slings, Conventional Vaginal Slings, Pubovaginal Slings, Others), By Material Type (Tissue & Synthetic Slings), By Type of Urinary Incontinence & By Region - Global Market Insights 2022-2032
Analysis of Vaginal Slings Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Vaginal Slings Market Outlook (2022-2032)
The global vaginal slings market is estimated to be valued at US$ 2.07 billion in 2022, and is forecast to surpass US$ 3.21 billion valuation by the end of 2032, expanding at a CAGR of 4.5% over the 2022 to 2032 projection period.
Vaginal slings are further classified into transobturator slings, mini slings/single incision slings, conventional vaginal slings, advanced vaginal slings, tension-free vaginal tape slings, and pubovaginal slings. Demand for transobturator slings is predicted to rise at a CAGR of 5% from 2022 to 2032. This can be ascribed to their effective advantages over other types, such as low chances of bladder injuries, bowel & major blood artery injuries, and effectiveness comparable to tension-free vaginal tape slings.
In addition to the advantages of these slings, rising rate of the elderly population who are more susceptible to urine incontinence symptoms and increasing prevalence of female urine incontinence are factors boosting the sales of transobturator slings.
- According to the National Center for Biotechnology Information's 2021 study, 423 million people irrespective of their gender (20 and older) globally suffer from urine incontinence across the globe.
Additionally, the growing demand for minimally-invasive surgical procedures is also fuelling product sales growth.
Urinary incontinence, an undetected condition in which the bladder loses control and causes an involuntary flow of pee, is treated with vaginal slings. Some of the behaviours that can cause urine leakage are coughing, laughing, sneezing, lifting heavy objects, and exercising. Vaginal slings support and hold the urethra and bladder like a hammock to stop leakage.
A common type of surgery performed for such conditions is a vaginal sling surgery, where slings are made from natural or synthetic materials such as cadaver tissues, pig or cow tissues, human tissues, or mesh (tissue slings or synthetic slings).
Urinary incontinence symptoms can be seen due to several conditions, including urinary tract infections, weakened pelvic floor muscles and urethral sphincters, menopause, pregnancy, and childbirth.
Furthermore, during the forecast period, the worldwide demand for novel vaginal slings is anticipated to rise due to the rising prevalence of urine incontinence, and technological advancements in vaginal slings. One of the main reasons influencing vaginal sling sales during the projected period is the increased emphasis on minimising maternal death instances and growing healthcare spending power.
As incontinence concerns may emerge during pregnancy and after childbirth, WHO and UNFPA, for instance, have set five essential objectives to minimize unnecessary maternal mortality, which further could support the demand for urethral vaginal slings.
Vaginal Slings Market Size (2022E)
US$ 2.07 Billion
Forecasted Market Value (2032F)
US$ 3.21 Billion
Global Market Growth Rate (2022-2032)
China Market Growth Rate (2022-2032)
Key Companies Profiled
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Market Trends are Expected to Drive Revenue Growth of Vaginal Sling Solution Manufacturers?
“Rising Worldwide Prevalence of Urinary Incontinence Disorder”
Midurethral sling surgeries are also known as vaginal sling surgeries. This surgical technique is typically carried out for the treatment of urinary incontinence.
Millions of people around the world experience urinary incontinence, a highly widespread urological illness that is both underreported and underdiagnosed. It harms the mental, emotional, and physical health of the patent.
Women are twice as likely to be affected as men, and the prevalence rises with age. Urinary incontinence may be caused due to various reasons, including urethral sphincters, obesity, urinary tract infections, and neurological abnormalities.
The most prevalent type of urine incontinence, stress urinary incontinence, affects millions of people globally. Several studies have revealed that over 45% of women over 30 years of age worldwide experience stress urine incontinence.
There are several types of urine incontinence such as stress urinary incontinence, urge urinary incontinence, and mixed urinary incontinence.
Colposuspension and vaginal mesh were two common but old therapeutic options. However, due to the midurethral sling's reputation as an effective, safe, and efficient procedure, old procedures have been supplanted.
In addition, vaginal sling procedures are gaining popularity because it requires less recovery and operational time. Global manufacturers of vaginal slings are witnessing potential demand opportunities as a result of all these features of the vaginal sling treatment.
What are the Limitations Denting Sales of Vaginal Slings?
“High Risk of UTIs During Vaginal Sling Procedures & Lack of Awareness of Urine Incontinence Treatment”
The potential risks of vaginal sling procedures, such as urinary tract infections (UTIs), together with the decrease in the number of women seeking medical examination and treatment for urine incontinence as a result of social stigma, and also lack of awareness about the treatment procedures in developing regions, could, however, limit business sales growth.
Which Strategies are Followed by Market Newcomers to Achieve High Profits?
“New Market Players Focused on Production of Vaginal Slings with Advanced Features”
New companies are focusing on developing advanced and cost-effective vaginal sling products, to earn a high market share and mark a dominant market position.
A U.S.-based Company Renovia, founded in 2016 is a producer of e-stimulation devices and solutions which focuses on the strengthening of pelvic floor muscles.
The business's solution enables real-time visualisation and treatment of weak pelvic floor muscles. Data management systems and patient-based app technologies are some of the features of the firm's product offerings.
For the treatment of women with stress, mixed, and mild to moderate urinary incontinence, the company offers a leva system and e-stimulation devices, which help to strengthen weak pelvic floor muscles.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Regions are Expected to Be Lucrative Markets for Vaginal Sling Treatment Providers?
“North America & Europe Profitable Markets Due to Large Patient Pool & Rising Prevalence of Neurological Disorders”
North America and Europe are expected to hold a dominating position in the global vaginal slings market during the forecast period. This can be attributed to the factors such as the large patient pool and the presence of major manufacturers of vaginal slings.
Furthermore, the rising geriatric population and rising prevalence of chronic diseases such as diabetes and neurological disorders are boosting the demand for vaginal slings in these regions.
Due to the rapidly improving healthcare infrastructure in nations such as India, China, Japan,South Korea, and Malaysia, the Asia Pacific market is expected to rise at an exponential rate. Additionally, it is anticipated that rising investments by top industry players and healthcare providers will boost the local market in the Asia Pacific region.
Demand for vaginal sling procedures in Latin America and the MEA regions is predicted to rise at a steady pace during the projected period.
How are Sales of Vaginal Sling Solutions Evolving in European Countries?
“Rising Prevalence of UTIs in European Region Driving Demand for Vaginal Sling Treatment”
Demand for vaginal sling treatment in European countries such as the U.K., Germany, Span, and France is expected to increase due to the rising prevalence of urinary tract infections among women.
- For instance, according to recent research by the National Health Service, between 3-6 million people in the U.K., currently deal with urinary incontinence.
- According to EUROMED research, approx. 6 to 8 million people in Germany currently experience urinary incontinence problems.
Rising incidence of this disease, along with the development of cutting-edge tools for minimally-invasive surgeries, is likely to increase the demand for vaginal mesh sling procedures in the European region.
Why is the United States Expected a Beneficial Marketplace for Suppliers of Vaginal Slings?
“Presence of Advanced Healthcare Infrastructure & Rising Elderly Population with Urinary Disorders”
The United States holds a dominating position in the North American vaginal slings market due to the presence of key manufacturers & the rising senior population with urinary disorders, and advanced healthcare facilities.
- According to recent studies by the National Association for Incontinence, more than 25 million Americans experience daily bladder leakage, with women accounting for the majority of incidences.
Thus, all the above-mentioned factors are expected to increase the demand for vaginal sling surgeries in the U.S. during the forecast period.
Why is There High Demand for Vaginal Sling Products from Hospitals?
“Existence of Skilled Medical Staff & Medical Technologies in Hospitals”
Vaginal sling surgeries are highly performed in hospitals. This can be attributed to the adoption of highly advanced robot-assisted minimally- invasive surgical equipment.
Governments of several nations across the globe are focusing on advancing their respective healthcare facilities.
- For instance, to assist rural hospitals and promote the rehabilitation and building of rural healthcare institutions, the United States Administration issued $500 million in American Rescue Act grants in 2021.
Over the coming years, developments such as these are projected to drive the overall market dynamics, together with the gradually rising surgical rate in hospitals.
Moreover, target patients primarily prefer hospitals for treatment procedures, due to the presence of advanced technologies and skilled healthcare experts, which subsequently boosts demand for vaginal slings.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Top companies are focusing on producing advanced vaginal sling solutions to increase their market position and earn high a revenue share in the vaginal slings market.
- Boston Scientific Corporation, one of the top market players, has a wide range of product folio with advanced vaginal sling solutions, used in the treatment of urinary disorders.
- For people with stress urine incontinence, Boston Scientific Corporation introduced the AdVance XP Male Sling System in February 2019.
- For instance, Desara TVez, a pelvic sling system developed by Caldera Medical in December 2021 to treat women with stress urinary incontinence and other pelvic health issues, is the latest addition to the Desara family of pelvic sling systems.
Key Segments of Vaginal Slings Industry Research
- Transobturator Slings
- Mini Slings/Single Incision Slings
- Conventional Vaginal Slings
- Advanced Vaginal Slings
- Tension-free Vaginal Tape Slings
- Pubovaginal Slings
By Material Type:
- Tissue Slings
- Synthetic Slings
By Type of Urinary Incontinence:
By End User:
- Ambulatory Surgical Centers
- North America
- Latin America
- East Asia
- South Asia & Oceania
- FAQs -
The market is segmented based on type, material type, type of incontinence, end user, and region.
The global vaginal slings market is projected to reach US$ 3.21 billion by 2032.
Sales of vaginal slings are predicted to increase at 4.5% CAGR from 2022 to 2032.
Worldwide demand for vaginal slings is currently valued at US$ 2.07 billion.
Some of the key players profiled in the report are Becton, Dickinson Company, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Inc., Coloplast A/S, Cook Medical, Inc., Ethicon US LLC, and ProSurg, Inc.